Overview

Magnetic Resonance Imaging Using Ferumoxtran-10 in Finding Metastases to the Axillary Lymph Nodes in Patients With Breast Cancer

Status:
Completed

Trial end date:
2006-10-01

Target enrollment:

Participant gender:

Summary

RATIONALE: Diagnostic procedures, such as magnetic resonance imaging (MRI) using ferumoxtran-10, may help find and diagnose breast cancer that may have spread to the axillary lymph nodes and may help in planning breast cancer treatment. PURPOSE: This phase II trial is studying how well MRI using ferumoxtran-10 works in finding metastases to the axillary lymph nodes in patients with invasive breast cancer.

Phase:

Phase 2

Details

Lead Sponsor:

Virginia Commonwealth University

Collaborator:

National Cancer Institute (NCI)